Calithera Biosciences (CALA) Q2 2022 Earnings Call Transcript

Calithera Biosciences (CALA) Q2 2022 Earnings Call Transcript

Joining me today are Susan Molineaux, founder, president, and CEO; and Emil Kuriakose, chief medical officer. Before we begin, I would like to remind you that today's discussion will include statements about our future expectations, plans, and prospects that constitute forward-looking statements for purposes of the safe harbor provision under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in the risk factors section of our periodic filings with the SEC.